Autoantibodies like rheumatoid factor (RF) and anti-citrullinated peptide antibodies (ACPA) are present in the peripheral blood of RA patients up to a decade before the clinical onset of synovitis and diagnosis (RA-risk individuals) (1–4). Here, PRTN3 is linked to rheumatoid arthritis.